FVCBankcorp Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

FVCBankcorp has total assets of $2.3B and total equity of $230.8M. Total deposits are $2.0B, and total loans are $1.9B. It earns a Net Interest Margin of 2.5%. It has sufficient allowance for bad loans, which are currently at 0.2% of total loans. Cash and short-term investments are $177.6M.

Belangrijke informatie

9.9x

Verhouding activa / eigen vermogen

2.5%

Nettorentemarge

Totaal deposito's	US$1.96b
Verhouding leningen/deposito's	Passend
Slechte leningen	0.2%
Voorziening voor dubieuze leningen	Voldoende
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	US$177.63m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

FVCBankcorp Non-GAAP EPS of $0.48 beats by $0.01, revenue of $18.1M beats by $0.6M

Oct 20

FVCBankcorp Non-GAAP EPS of $0.43 beats by $0.01, revenue of $17.44M beats by $2.04M

Jul 21

With EPS Growth And More, FVCBankcorp (NASDAQ:FVCB) Is Interesting

Jun 08

We Think Some Shareholders May Hesitate To Increase FVCBankcorp, Inc.'s (NASDAQ:FVCB) CEO Compensation

May 13

What You Need To Know About FVCBankcorp, Inc.'s (NASDAQ:FVCB) Investor Composition

Mar 13

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: FVCB's Assets to Equity ratio (9.9x) is low.

Voorziening voor slechte leningen: FVCB has a sufficient allowance for bad loans (536%).

Laag risico verplichtingen: 95% of FVCB's liabilities are made up of primarily low risk sources of funding.

Leenniveau: FVCB has an appropriate level of Loans to Assets ratio (81%).

Laag risico deposito's: FVCB's Loans to Deposits ratio (95%) is appropriate.

Niveau van slechte leningen: FVCB has an appropriate level of bad loans (0.2%).

FVCBankcorp Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Independent Director recently sold US$51k worth of stock

Independent Director exercised options and sold US$57k worth of stock

Investor sentiment deteriorates as stock falls 17%

CEO & Chairman recently sold US$51k worth of stock

CEO & Chairman notifies of intention to sell stock

New major risk - Revenue and earnings growth

Investor sentiment improves as stock rises 18%

Price target decreased by 7.4% to US$12.50

Executive VP & COO exercised options to buy US$323k worth of stock.

Independent Director exercised options to buy US$249k worth of stock.

Independent Director recently sold US$137k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$114k worth of stock

Independent Director notifies of intention to sell stock

Consensus EPS estimates fall by 21%

Investor sentiment deteriorates as stock falls 16%

FVCBankcorp, Inc., Annual General Meeting, May 15, 2024

Chairman & CEO recently sold US$118k worth of stock

Independent Director exercised options and sold US$95k worth of stock

Independent Director exercised options and sold US$65k worth of stock

Executive VP & Chief Lending Officer exercised options and sold US$97k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$370k worth of stock

Insufficient new directors

Executive VP & Chief Lending Officer recently sold US$72k worth of stock

Consensus EPS estimates fall by 34%

FVCBankcorp, Inc. Announces Executive Changes

Chairman & CEO recently sold US$83k worth of stock

New minor risk - Profit margin trend

Independent Director recently sold US$100k worth of stock

Investor sentiment deteriorates as stock falls 16%

Independent Director recently sold US$90k worth of stock

FVCBankcorp, Inc. Reports Net Charge-Offs for the Second Quarter Ended June 30, 2023

FVCBankcorp, Inc. Announces Resignation of Thomas L Patterson, Director

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 16%

Executive VP & CFO recently bought US$60k worth of stock

Consensus revenue estimates fall by 11%

Price target decreased by 12% to US$12.75

Full year 2022 earnings: EPS and revenues miss analyst expectations

Now 27% undervalued after recent price drop

Independent Director recently sold US$183k worth of stock

Independent Director recently sold US$100k worth of stock

Consensus EPS estimates fall by 11%

Price target decreased by 12% to US$19.38

FVCBankcorp, Inc. Reports Unaudited Net Charge-Offs for the Fourth Quarter Ended December 31, 2022

Now 22% undervalued after recent price drop

Full year 2022 earnings: EPS and revenues miss analyst expectations

Independent Director notifies of intention to sell stock

President exercised options and sold US$72k worth of stock

FVCbank Taps Bruce Gemmill as Senior Vice President / Chief Marketing Officer

Independent Director recently sold US$99k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$102k worth of stock

Independent Director notifies of intention to sell stock

Independent Director recently sold US$103k worth of stock

Third quarter 2022 earnings: EPS exceeds analyst expectations

FVCBankcorp Non-GAAP EPS of $0.48 beats by $0.01, revenue of $18.1M beats by $0.6M

FVCBankcorp, Inc. and FVCbank Appoints Marc N. Duber to Board of Directors

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

FVCBankcorp Non-GAAP EPS of $0.43 beats by $0.01, revenue of $17.44M beats by $2.04M

Price target decreased to US$22.17

Independent Director recently sold US$323k worth of stock

First quarter 2022 earnings: EPS misses analyst expectations

Insufficient new directors

First quarter 2022 earnings: EPS misses analyst expectations

Insufficient new directors

Fvcbankcorp, Inc. Announces That Morton A. Bender, A Director of the Company, Passed Away on April 11, 2022

FVCBankcorp, Inc., Annual General Meeting, May 18, 2022

Blue Ridge Bankshares, Inc. (NYSEAM:BRBS) cancelled the acquisition of FVCBankcorp, Inc. (NASDAQ:FVCB) in a merger of equals.

Now 21% undervalued after recent price drop

Independent Director exercised options to buy US$371k worth of stock.

Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.29 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.38 (vs US$0.21 in 2Q 2020)